The identification of NKG7 as a regulator of cytotoxic lymphocyte function and inflammatory responses suggests that targeting this molecule may be a therapeutic approach to treat diverse conditions including infection, autoimmune diseases and cancer. The gene discussed is NKG7; the disease is cancer.